BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31143932)

  • 21. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Experience With Sternotomy Versus Subcostal Approach for Exchange of HeartMate II Left Ventricular Assist Device.
    Soleimani B; Stephenson ER; Price LC; El-Banayosy A; Pae WE
    Ann Thorac Surg; 2015 Nov; 100(5):1577-80. PubMed ID: 26233277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A real-life experience with HeartMate III.
    Marasco SF; Farag J; Kure C; Summerhayes R; Bailey M; McGiffin D
    J Card Surg; 2019 Oct; 34(10):1031-1036. PubMed ID: 31376201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First series of left ventricular assist device exchanges to HeartMate 3.
    Hanke JS; Rojas SV; Dogan G; Feldmann C; Beckmann E; Deniz E; Wiegmann B; Michaelis JE; Napp LC; Berliner D; Shrestha M; Bauersachs J; Haverich A; Schmitto JD
    Eur J Cardiothorac Surg; 2017 May; 51(5):887-892. PubMed ID: 28329060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HeartMate II Left Ventricular Assist Device Geometry on Chest Radiograph Does Not Correlate with Risk of Pump Thrombosis.
    Han JJ; Gaffey AC; Sooppan R; Hung G; Venkataraman C; Phillips E; Howard J; McLean R; Acker MA; Atluri P
    ASAIO J; 2016; 62(2):128-32. PubMed ID: 26720737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
    Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
    J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular assist device exchange: the Toronto General Hospital experience.
    Tsubota H; Ribeiro RVP; Billia F; Cusimano RJ; Yau TM; Badiwala MV; Stansfield WE; Rao V
    Can J Surg; 2017 Aug; 60(4):253-259. PubMed ID: 28562236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with the HeartMate II Left Ventricular Assist Device in Patients Older than 60 Years.
    Demirozu ZT; Critsinelis A; Cohn WE; Radovancevic R; Ho J; Hernandez R; Morgan JA; Frazier OH
    Heart Surg Forum; 2019 Mar; 22(2):E124-E130. PubMed ID: 31013222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices.
    Mutsuga M; Okumura T; Morimoto R; Kondo T; Ito H; Terazawa S; Tokuda Y; Narita Y; Nishida K; Murohara T; Usui A
    Artif Organs; 2023 Feb; 47(2):387-395. PubMed ID: 36269680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial experience with routine less invasive implantation of HeartMate II left ventricular assist device without median sternotomy.
    Anyanwu AC; Itagaki S; Pinney S; Adams DH
    Eur J Cardiothorac Surg; 2014 Dec; 46(6):985-90. PubMed ID: 24623169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year outcomes with the HeartMate 3 left ventricular assist device.
    Hanke JS; Dogan G; Zoch A; Ricklefs M; Wert L; Feldmann C; Bara C; Shrestha M; Tillmanns J; Kempf T; Bauersachs J; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):662-669. PubMed ID: 29525258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical).
    Kitahara H; Raikhelkar J; Kim G; Sarswat N; Sayer G; Uriel N; Song T; Onsager D; Jeevanandam V; Ota T
    J Artif Organs; 2019 Sep; 22(3):181-187. PubMed ID: 30976935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative Outcomes of the Largest HeartMate-II Experience in Turkey.
    Ertugay S; Engin C; Nalbantgil S; Kocabaş S; Balcioglu O; Engin Y; Yagdi T; Ozbaran M
    Transplant Proc; 2015 Jun; 47(5):1499-502. PubMed ID: 26093751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Approach With Subcostal Exchange of the HeartMate II Left Ventricular Assist Device: Difference in On and Off Pump?
    Gaffey AC; Chen CW; Chung JJ; Phillips E; Wald J; Williams ML; Low DW; Acker MA; Atluri P
    Ann Thorac Surg; 2017 Nov; 104(5):1540-1546. PubMed ID: 28760470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.